Biotherapeutics startup Hummingbird Bioscience brings its overall Series B funding to $25 million

Biotherapeutics startup Hummingbird Bioscience brings its overall Series B funding to $25 million

Hummingbird Bioscience, a start-up concentrated on developing new treatments for cancer and other illness, revealed today it has actually added$6 million to its formerly announced Series B, bringing the round’s overall to$25 million. The extension was led by SK Holdings, and consisted of involvement from returning investors consisting of Heritas Capital and SEEDS Capital, the financial investment […]
The brand-new funding will be utilized to take treatments Hummingbird Bioscience is establishing to scientific trials more rapidly, and expand research and advancement for its early stage pipeline. Heritas Capital Management executive director and CEO Chik Wai Chiew stated in a press statement that”Heritas Capital is pleased to continue our backing of the Hummingbird group considering that leading its Series A extended round. …